title: Diabetes and cardiovascular risk factor controls in Thai type 2 diabetes with no history of cardiovascular complications; situation and compliance to diabetes management guideline in Thailand.
abstract: BACKGROUND
  Cardiovascular complication is one of the most important issues causing morbidity and death in diabetic patients. Primary prevention is a key to prevent this complication.
  
  
  OBJECTIVE
  The objective was to study the situations of diabetes and cardiovascular risk factor controls in Thai type 2 diabetic patients who had no history of cardiovascular complication at a university hospital in Thailand after the Thai diabetes management guideline was recently launched.
  
  
  METHODS
  The study was a cross-sectional survey in type 2 diabetes patients with no history of cardiovascular disease. Seven hundred and fourteen patients were enrolled in the study and 54.3% were females. The data were collected retrospectively from out-patient medical records and an electronic data base for the patients who were followed up at the hospital during January-December 2010. The most recent laboratory values were utilized in the analysis.
  
  
  RESULTS
  70%-90% of all patients were checked for HbA1c and lipid profiles (LDL-C, total cholesterol, triglycerides) at least once a year. It was observed that only 28% of the patients had HbA1c<6.5%. Furthermore, the percentages of the patients who had blood pressure <130/80 mmHg, and who had LDL-C<100 mg/dL were 28% and 41%, respectively.
  
  
  CONCLUSIONS
  Even though the practice guideline has been launched since 2008, diabetes, hypertension and dyslipidemia were still poorly controlled. Further study is recommended to identify factors influencing these outcomes as well as the policy of diabetic care in Thailand is needed to be seriously implemented.
authors.affiliation: Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Pharmaceutical Care Research Unit, Naresuan University, Phitsanulok, Thailand. patcharaporns2000@yahoo.com
authors.forename: Patcharaporn
authors.initials: P
authors.lastname: Sudchada
authors.forename: Chayada
authors.initials: C
authors.lastname: Khom-Ar-Wut
authors.forename: Anuchit
authors.initials: A
authors.lastname: Eaimsongchram
authors.forename: Saksipong
authors.initials: S
authors.lastname: Katemut
authors.forename: Piwadee
authors.initials: P
authors.lastname: Kunmaturos
authors.forename: Rawisut
authors.initials: R
authors.lastname: Deoisares
mesh_terms: D000368:Aged; D002318:Cardiovascular Diseases / Q000097:blood* / Q000209:etiology; D002784:Cholesterol / Q000097:blood; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications; D058065:Diabetic Cardiomyopathies / Q000097:blood*; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000209:etiology; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D017410:Practice Guidelines as Topic; D012189:Retrospective Studies; D012307:Risk Factors; D013785:Thailand
chemical_list: D002784:Cholesterol; D006442:Glycated Hemoglobin; D008055:Lipids; C517652:hemoglobin A1c protein, human